ISRG · Intuitive Surgical Inc
$373.57
-5.24 (-1.38%)
At close · Aug 24
Market Cap
$133.60B
Shares
353.28M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$10.06B
+20.5%
FY2025
Net Income
$2.86B
+23%
FY2025
Gross Margin
66%
-1.5pp
FY2025
Operating Margin
29.27%
+1.2pp
FY2025
Diluted EPS
$7.87
+22.6%
FY2025
Operating Cash Flow
$3.03B
+25.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $11.03B | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B | $2.38B | $2.13B | $2.27B | $2.18B | $1.76B | $1.41B | $1.05B | $874.9M | $600.83M | |
| $977.3M | $874.3M | $654.2M | $500.5M | $376.5M | $276.9M | $176.7M | $106.9M | $51.4M | $25.9M | $16.6M | $7M | $1.3M | $0 | — | — | — | — | — | — | |
| $3.68B | $3.42B | $2.72B | $2.39B | $2.03B | $1.75B | $1.5B | $1.37B | $1.12B | $934.8M | $814.3M | $806.5M | $717.9M | $670.9M | $608.5M | $483.5M | $383M | $301.1M | $254.1M | $186.54M | |
| $7.36B | $6.64B | $5.63B | $4.73B | $4.2B | $3.96B | $2.86B | $3.11B | $2.6B | $2.2B | $1.89B | $1.58B | $1.41B | $1.59B | $1.57B | $1.27B | $1.03B | $751.1M | $620.8M | $414.29M | |
| — | 66% | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.17% | 69.94% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.96% | 68.95% | |
| $1.41B | $1.31B | $1.15B | $998.8M | $879M | $671M | $595.1M | $557.3M | $418.1M | $328.6M | $239.6M | $197.4M | $178M | $167.7M | $170M | $140.2M | $116M | $95.1M | $79.4M | $48.86M | |
| $2.49B | $2.39B | $2.14B | $1.96B | $1.74B | $1.47B | $1.22B | $1.18B | $986.6M | $810.5M | $703.6M | $640.5M | $691M | $574M | $522.2M | $438.8M | $358.8M | $278.6M | $230.6M | $158.69M | |
| $37.7M | $13.2M | $16.7M | $20.2M | $27.8M | $27.4M | $49.8M | $43M | $14.2M | $12.9M | $18.2M | $24.4M | $22.4M | $21.3M | $23.1M | $17.8M | $16.7M | $15.6M | $10.5M | $2.02M | |
| $3.91B | $3.7B | $3.29B | $2.96B | $2.62B | $2.14B | $1.81B | $1.74B | $1.4B | $1.14B | $943.2M | $837.9M | $869M | $741.7M | $692.2M | $579M | $474.8M | $373.7M | $310M | $207.54M | |
| $3.45B | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.2B | $1.06B | $949.7M | $740M | $544.8M | $852.5M | $878.1M | $694.8M | $555.2M | $377.4M | $310.8M | $206.74M | |
| — | 29.27% | 28.12% | 24.8% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.87% | 35.09% | 31.04% | 25.56% | 37.64% | 40.3% | 39.54% | 39.29% | 35.87% | 35.52% | 34.41% | |
| $354.6M | $365.9M | $324.9M | $192.1M | $29.7M | $69.3M | $157.2M | $127.7M | $80.1M | $41.9M | $35.6M | $18.5M | $4.2M | $18.4M | $15.8M | $14.9M | $17.1M | $18.7M | $24.4M | $30.49M | |
| $3.81B | $3.31B | $2.67B | $1.96B | $1.61B | $1.89B | $1.21B | $1.5B | $1.28B | $1.1B | $985.3M | $758.5M | $549M | $870.9M | $893.9M | $709.7M | $572.3M | $396.1M | $335.2M | $237.23M | |
| $647.9M | $434.8M | $336.3M | $141.6M | $262.4M | $162.2M | $140.2M | $120.4M | $154.5M | $433.9M | $247M | $169.7M | $130.2M | $199.9M | $237.3M | $214.6M | $190.5M | $163.5M | $130.9M | $92.7M | |
| $3.14B | $2.86B | $2.32B | $1.8B | $1.32B | $1.7B | $1.06B | $1.38B | $1.13B | $670.9M | $738.3M | $588.8M | $418.8M | $671M | $656.6M | $495.1M | $381.8M | $232.6M | $204.3M | $144.54M | |
| — | 28.38% | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% | 30.8% | 30.29% | 21.38% | 27.28% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | |
| $19.1M | $20.6M | $14.9M | $19.3M | $22.1M | $23.5M | $6.2M | $2.5M | -$2.9M | -$400K | — | — | — | — | — | — | — | — | — | — | |
| $3.14B | $2.95B | $2.28B | $1.95B | $1.18B | $1.66B | $1.07B | $1.41B | $1.13B | $664.3M | $738.9M | $584.4M | $411.6M | $666.5M | $662.3M | $494.4M | $382.1M | $236.8M | $200.8M | $144.36M | |
| USD/shares | — | $8.00 | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 | $3.98 | $3.31 | $2.00 | $2.14 | $1.76 | $3.78 | $5.71 | $5.50 | $4.21 | $3.25 | $2.02 | $1.75 | $1.27 |
| USD/shares | — | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 | $1.73 | $3.70 | $5.58 | $5.33 | $4.11 | $3.16 | $1.98 | $1.71 | $1.23 |
| shares | — | 356.9M | 355.2M | 351.2M | 355.7M | 356.1M | 351.1M | 346.2M | 341.1M | 335.1M | 344.7M | 333.9M | 110.7M | 117.6M | 119.4M | 117.6M | 117.6M | 114.9M | 116.7M | 113.49M |
| shares | — | 362.7M | 362M | 357.4M | 362M | 365.8M | 361M | 358.4M | 356.4M | 348.9M | 353.7M | 341.1M | 113.1M | 120.3M | 123.3M | 120.6M | 120.9M | 117.6M | 119.7M | 117.06M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $11.25B in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.56×
EV/EBIT
—
Peer median 29.58×
P/E (TTM)
43.42×
Peer median 33.76×
Peer medians compare against the 7 similar-size Medical Instruments & Supplies companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Instruments and Accessories | $6,018,900,000 | $5,079,000,000 | $4,276,600,000 | $3,517,900,000 | $3,100,500,000 | $2,455,700,000 | $2,408,200,000 | $1,962,000,000 |
| Systems | $2,473,700,000 | $1,966,000,000 | $1,679,700,000 | $1,680,100,000 | $1,693,400,000 | $1,178,900,000 | $1,346,100,000 | $1,127,100,000 |
| Service | $1,572,100,000 | $1,307,100,000 | $1,167,800,000 | $1,024,200,000 | $916,200,000 | $723,800,000 | $724,200,000 | $635,100,000 |
Key facts
CIK
1035267
CUSIP
46120E602
13F (30d)
1687 filings
1604 filers
Visit website
Investor relations